$20.53
0.12%
Nasdaq, Oct 05, 11:16 am EDT. Market open.

Innoviva Target price 2026 - Analyst rating & recommendation

Innoviva Classifications & Recommendation

Buy
82%
Hold
9%
Sell
9%

Innoviva Price Target

Target Price $38.76
Price $20.50
Potential
Number of Estimates 6
6 Analysts have issued a price target Innoviva 2027 . The average Innoviva target price is $38.76. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 9 Analysts recommend Innoviva to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Innoviva stock has an average upside potential 2027 of . Most analysts recommend the Innoviva stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 411.33 460.21
14.67% 11.88%
EBITDA Margin 49.59% 50.86%
7.73% 2.57%
Net Margin 65.93% 35.82%
911.03% 45.67%

7 Analysts have issued a sales forecast Innoviva 2026 . The average Innoviva sales estimate is

$460m
unlock
. This is
4.59% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$516m 17.36%
unlock
, the lowest is
$413m 6.11%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $411m 14.67%
2026
$460m 11.88%
unlock
2027
$497m 7.99%
unlock
2028
$509m 2.38%
unlock
2029
$598m 17.55%
unlock
2030
$628m 4.96%
unlock
2031
$435m 30.77%
unlock
2032
$487m 11.96%
unlock
2033
$538m 10.65%
unlock

4 Analysts have issued an Innoviva EBITDA forecast 2026. The average Innoviva EBITDA estimate is

$234m
unlock
. This is
15.31% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$245m 20.64%
unlock
, the lowest is
$221m 8.97%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $204m 5.81%
2026
$234m 14.76%
unlock
2027
$254m 8.50%
unlock
2028
$237m 6.56%
unlock

EBITDA Margin

2025 49.59% 7.73%
2026
50.86% 2.57%
unlock
2027
51.10% 0.47%
unlock
2028
46.64% 8.73%
unlock

7 Innoviva Analysts have issued a net profit forecast 2026. The average Innoviva net profit estimate is

$165m
unlock
. This is
53.85% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$195m 45.34%
unlock
, the lowest is
$106m 70.31%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $271m 1,059.34%
2026
$165m 39.20%
unlock
2027
$171m 3.59%
unlock
2028
$146m 14.53%
unlock
2029
$250m 71.07%
unlock

Net Margin

2025 65.93% 911.03%
2026
35.82% 45.67%
unlock
2027
34.37% 4.05%
unlock
2028
28.69% 16.53%
unlock
2029
41.75% 45.52%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 3.19 2.27
929.03% 28.84%
P/E 9.03
EV/Sales 2.52

7 Analysts have issued a Innoviva forecast for earnings per share. The average Innoviva EPS is

$2.27
unlock
. This is
53.29% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.69 44.65%
unlock
, the lowest is
$1.46 69.96%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $3.19 929.03%
2026
$2.27 28.84%
unlock
2027
$2.35 3.52%
unlock
2028
$2.01 14.47%
unlock
2029
$3.44 71.14%
unlock
2030
$7.95 131.10%
unlock
2031
$9.33 17.36%
unlock
2032
$10.53 12.86%
unlock

P/E ratio

Current 4.22 89.94%
2026
9.03 114.08%
unlock
2027
8.72 3.43%
unlock
2028
10.20 16.97%
unlock
2029
5.96 41.57%
unlock

Based on analysts' sales estimates for 2026, the Innoviva stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.64 14.29%
2026
2.52 4.49%
unlock
2027
2.34 7.40%
unlock
2028
2.28 2.32%
unlock
2029
1.94 14.93%
unlock
2030
1.85 4.73%
unlock
2031
2.67 44.44%
unlock

P/S ratio

Current 3.37 4.85%
2026
3.22 4.39%
unlock
2027
2.98 7.40%
unlock
2028
2.91 2.32%
unlock
2029
2.48 14.93%
unlock
2030
2.36 4.73%
unlock
2031
3.41 44.43%
unlock

Current Innoviva Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Cantor Fitzgerald
Locked
➜
Locked
Locked Aug 07 2026
BTIG
Locked
➜
Locked
Locked Jun 22 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jun 01 2026
BTIG
Locked
➜
Locked
Locked May 26 2026
BTIG
Locked
➜
Locked
Locked May 07 2026
BTIG
Locked
➜
Locked
Locked Feb 26 2026
BTIG
Locked
➜
Locked
Locked Feb 17 2026
Analyst Rating Date
Locked
Cantor Fitzgerald:
Locked
➜
Locked
Aug 07 2026
Locked
BTIG:
Locked
➜
Locked
Jun 22 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jun 01 2026
Locked
BTIG:
Locked
➜
Locked
May 26 2026
Locked
BTIG:
Locked
➜
Locked
May 07 2026
Locked
BTIG:
Locked
➜
Locked
Feb 26 2026
Locked
BTIG:
Locked
➜
Locked
Feb 17 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today